HCP Given Consensus Rating of “Hold” by Analysts (NYSE:HCP)
HCP (NYSE:HCP) has been given a consensus recommendation of “Hold” by the nine ratings firms that are currently covering the stock, AnalystRatingsNetwork reports. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year price target among analysts that have covered the stock in the last year is $41.63.
HCP (NYSE:HCP) opened at 43.31 on Thursday. HCP has a 52-week low of $35.50 and a 52-week high of $44.51. The stock’s 50-day moving average is $42.09 and its 200-day moving average is $40.72. The company has a market cap of $19.871 billion and a P/E ratio of 19.74.
HCP (NYSE:HCP) last announced its earnings results on Tuesday, August 5th. The company reported $0.75 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.75. The company had revenue of $536.12 million for the quarter, compared to the consensus estimate of $523.50 million. During the same quarter last year, the company posted $0.72 earnings per share. HCP’s revenue was up 4.7% compared to the same quarter last year. On average, analysts predict that HCP will post $3.03 earnings per share for the current fiscal year.
In other HCP news, EVP Thomas D. Kirby unloaded 672 shares of the company’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $43.25, for a total value of $29,064.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
A number of analysts have recently weighed in on HCP shares. Analysts at Zacks reiterated a “neutral” rating on shares of HCP in a research note on Wednesday. They now have a $45.00 price target on the stock. Separately, analysts at RBC Capital raised their price target on shares of HCP from $23.00 to $25.00 in a research note on Tuesday, August 5th. They now have an “outperform” rating on the stock. Finally, analysts at Mizuho initiated coverage on shares of HCP in a research note on Wednesday, July 23rd. They set a “buy” rating on the stock.
HCP, Inc (NYSE:HCP) is a real estate investment trust (REIT).
Receive News & Ratings for HCP Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.